Use of CXCL13 as biomarker in diagnostic reagent

A technology of biomarkers and diagnostic reagents, which is applied in the field of preparation or screening of diagnostic reagents for Candida infection, and can solve problems such as the inapplicability of diagnostic methods to clinical applications

Active Publication Date: 2018-01-09
CHONGQING MEDICAL UNIVERSITY
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In view of the shortcomings of the prior art described above, the purpose of the present invention is to provide the use of CXCL13 as a biomarker in the preparation or screening of di

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of CXCL13 as biomarker in diagnostic reagent
  • Use of CXCL13 as biomarker in diagnostic reagent
  • Use of CXCL13 as biomarker in diagnostic reagent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Detection of Serum CXCL13 in Patients with Bloodstream Infection

[0035]The blood samples of clinical patients are tested for relevant pathogens by the microbiology room of the laboratory department. After the test is completed, the serum samples of the patients on the day of submission are collected. At the same time, the serum samples of patients with negative pathogen tests are collected as controls, and they are immediately stored in a -80°C refrigerator. For subsequent experiments. All patients were divided into 3 groups: candidemia group (candidemia group), bacteremia group (bacteremia group) and pathogen detection negative group (Control group), ELISA method was used to detect 56 candidemia patients, 56 bacterial The sera of patients with hyperemia and 36 patients with negative pathogen tests were collected. In addition, patients with cancer, autoimmune diseases and other acute infections that affect the expression of CXCL13 were excluded. The human CXCL13 ELIS...

Embodiment 2

[0038] ROC curve analysis compared the diagnostic performance of serum CXCL13, BDG, CRP and PCT in invasive candida infection.

[0039] The laboratory indicators of the candidemia group and the control group were collected through the laboratory LIS system, including G test (BDG), CRP and PCT. Use SPSS19.0 software to make ROC curve, and use MedCalc15.8 software to compare the statistical difference of the area under the ROC curve.

[0040] The result is as figure 2 As shown, the ROC curve analyzes the diagnostic value of different indicators in invasive candida infection, and the areas under the curve of serum CXCL13, CRP, PCT, and BDG are 0.917, 0.792, 0.769, and 0.934, respectively. CXCL13 vs CRP, P0.05.

[0041] From the statistical results, it was found that the area under the curve of CXCL13 was significantly larger than that of CRP and PCT, and it was statistically significant, indicating that CXCL13 had a certain diagnostic value for invasive candida infection. Alt...

Embodiment 3

[0043] In order to further explore the role of CXCL13 in invasive Candida infection, the present invention constructs a mouse model of Candida bloodstream infection. The experimental mice included 24 6-8 week old female C57BL / 6 mice (purchased from the Experimental Animal Center of Chongqing Medical University), were randomly divided into 4 groups, and were injected with different doses of Candida SC5314 through the tail vein, including high dose ( 3*10 5 CFU / piece), medium dose (1*10 5 CFU / piece), low dose (5*10 4 CFU / only), with sterile PBS as control, the experiment was repeated twice. The successful establishment of the mouse bloodstream infection model was verified by detecting the changes in the body weight of the mice and the number of Candida colonies in the kidneys. Results The normality analysis was carried out with SPSS19.0 software, and the graph was drawn with GraphPad Prism 5.0 software. Normality data with mean ± standard deviation , the results are shown ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides use of CXCL13 as a biomarker in preparation or screening of diagnostic reagent for monilial infection. The use shows that CXCL13 can be taken as a novel biomarker for diagnosinginvasive monilial infection; and an in-vivo animal experiment shows that the expression level of CXCL13 can be increased by candidas of different strains, and the high expression of CXCL13 is in positive correlation with the seriousness of diseases, so that CXCL13 provided by the invention can be taken as a diagnostic and prognostic indicator for the invasive monilial infection.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the use of CXCL13 as a biomarker in the preparation or screening of diagnostic reagents for Candida infection. Background technique [0002] Candida is one of the most common normal flora in the human intestinal tract, widely present in the external environment and in the human body. In recent decades, the incidence of Candida bloodstream infection has been increasing. The main risk factors include surgery, the use of invasive medical equipment, the use of broad-spectrum antibiotics, and some underlying diseases (diabetes, tumors, blood diseases, and chronic renal failure. Wait). According to reports, Candida ranks third or fourth in bloodstream infections caused by pathogens, among which Candida albicans is the most common pathogen of invasive fungal infections, followed by Candida parapsilosis and Candida glabrata. Candidemia has a high morbidity, mortality and a large amount of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/6895C12Q1/6883C12Q1/04
Inventor 张莉萍曹炬李从雅
Owner CHONGQING MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap